PAR3 COST-EFFECTIVENESS OF LUMIRACOXIB COMPARED TO CELECOXIB FOR THE TREATMENT OF OSTEOARTHRITIS IN CANADA
May 1, 2007, 00:00
10.1016/S1098-3015(10)68895-X
https://www.valueinhealthjournal.com/article/S1098-3015(10)68895-X/fulltext
Title :
PAR3 COST-EFFECTIVENESS OF LUMIRACOXIB COMPARED TO CELECOXIB FOR THE TREATMENT OF OSTEOARTHRITIS IN CANADA
Citation :
https://www.valueinhealthjournal.com/action/showCitFormats?pii=S1098-3015(10)68895-X&doi=10.1016/S1098-3015(10)68895-X
First page :
Section Title :
Open access? :
No
Section Order :
69